0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Human Placental Protein - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-2K4481
Home | Market Reports | Health| Reproductive Health
Global Human Placental Protein Market Insights and Forecast to 2028
BUY CHAPTERS

Human Placental Protein - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-2K4481
Report
September 2024
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Placental Protein - Market Size

The global market for Human Placental Protein was estimated to be worth US$ 889.1 million in 2023 and is forecast to a readjusted size of US$ 1747.6 million by 2030 with a CAGR of 10.0% during the forecast period 2024-2030

Human Placental Protein - Market

Human Placental Protein - Market

A placenta is an organ that connects the developing fetus to the uterine wall to allow nutrient uptake, thermo-regulation, waste elimination, and gas exchange through the mothers blood supply. In addition, it aids in fighting against internal infection and produces hormones to support pregnancy. This placenta is further hydrolyzed and is used for a variety of applications as it has lactogenic, luteotropic, and growth-promoting action, and prevents maternal insulin action during pregnancy.
Skin Care Products are expected to dominate the global human placental protein market in the forecast period. This can be attributed to the rising prevalence of cosmetics products among the targeted population and the increasing number of menopause population. As the placenta connects developing fetus to the uterine wall to all nutrients uptake, thermoregulation, fighting against internal infection and produce hormones to support pregnancy, which makes placenta protein highly nutritious and thus it further hydrolyzed and use it for many skincare products and hair care treatments. In addition, with the increasing aging population worldwide, the human placental protein extract has been extensively used for anti-aging therapy and is promoting the growth of the overall market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Placental Protein, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Human Placental Protein by region & country, by Type, and by Application.
The Human Placental Protein market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Placental Protein.
Market Segmentation

Scope of Human Placental Protein - Market Report

Report Metric Details
Report Name Human Placental Protein - Market
Forecasted market size in 2030 US$ 1747.6 million
CAGR 10.0%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Japan Bio Products GmbH, R&D Systems, Inc, Abcam Plc, Clontech Laboratories, Inc, Lee Biosolutions, Inc, Kamiya Biomedical Company, Scripps Laboratories, VWR International, Elabscience Biotechnology Co.,Ltd, Hunan World Well-Being Bio-Tech Co., Ltd, Takara Bio Inc, MED Skincare, CJT, Charites Japan, Bioon, Japan Natural Laboratories, Height Long Jiang Yinhe, Albert David Ltd., MF3 LTD, SR GROUP, SGSTEMCELL, NOVA Biologics, Inc, Creative Enzymes, Melsmon Pharmaceutical Co., Ltd, Bovogen Biologicals Pty Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Human Placental Protein manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Human Placental Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Human Placental Protein in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Human Placental Protein - Market size in 2030?

Ans: The Human Placental Protein - Market size in 2030 will be US$ 1747.6 million.

Who are the main players in the Human Placental Protein - Market report?

Ans: The main players in the Human Placental Protein - Market are Japan Bio Products GmbH, R&D Systems, Inc, Abcam Plc, Clontech Laboratories, Inc, Lee Biosolutions, Inc, Kamiya Biomedical Company, Scripps Laboratories, VWR International, Elabscience Biotechnology Co.,Ltd, Hunan World Well-Being Bio-Tech Co., Ltd, Takara Bio Inc, MED Skincare, CJT, Charites Japan, Bioon, Japan Natural Laboratories, Height Long Jiang Yinhe, Albert David Ltd., MF3 LTD, SR GROUP, SGSTEMCELL, NOVA Biologics, Inc, Creative Enzymes, Melsmon Pharmaceutical Co., Ltd, Bovogen Biologicals Pty Ltd

What are the Application segmentation covered in the Human Placental Protein - Market report?

Ans: The Applications covered in the Human Placental Protein - Market report are Life Science, Tumor Markers, Testing/Assay Validation, Others

What are the Type segmentation covered in the Human Placental Protein - Market report?

Ans: The Types covered in the Human Placental Protein - Market report are Hydrolyzed Human Placental Protein, Human Placental Enzymes, Others

Recommended Reports

Placental Protein Markets

Human Recombinant Proteins

Pregnancy Related Care

1 Market Overview
1.1 Human Placental Protein Product Introduction
1.2 Global Human Placental Protein Market Size Forecast
1.3 Human Placental Protein Market Trends & Drivers
1.3.1 Human Placental Protein Industry Trends
1.3.2 Human Placental Protein Market Drivers & Opportunity
1.3.3 Human Placental Protein Market Challenges
1.3.4 Human Placental Protein Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Placental Protein Players Revenue Ranking (2023)
2.2 Global Human Placental Protein Revenue by Company (2019-2024)
2.3 Key Companies Human Placental Protein Manufacturing Base Distribution and Headquarters
2.4 Key Companies Human Placental Protein Product Offered
2.5 Key Companies Time to Begin Mass Production of Human Placental Protein
2.6 Human Placental Protein Market Competitive Analysis
2.6.1 Human Placental Protein Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Human Placental Protein Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Placental Protein as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hydrolyzed Human Placental Protein
3.1.2 Human Placental Enzymes
3.1.3 Others
3.2 Global Human Placental Protein Sales Value by Type
3.2.1 Global Human Placental Protein Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Placental Protein Sales Value, by Type (2019-2030)
3.2.3 Global Human Placental Protein Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Life Science
4.1.2 Tumor Markers
4.1.3 Testing/Assay Validation
4.1.4 Others
4.2 Global Human Placental Protein Sales Value by Application
4.2.1 Global Human Placental Protein Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Placental Protein Sales Value, by Application (2019-2030)
4.2.3 Global Human Placental Protein Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Human Placental Protein Sales Value by Region
5.1.1 Global Human Placental Protein Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Placental Protein Sales Value by Region (2019-2024)
5.1.3 Global Human Placental Protein Sales Value by Region (2025-2030)
5.1.4 Global Human Placental Protein Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Human Placental Protein Sales Value, 2019-2030
5.2.2 North America Human Placental Protein Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Human Placental Protein Sales Value, 2019-2030
5.3.2 Europe Human Placental Protein Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Human Placental Protein Sales Value, 2019-2030
5.4.2 Asia Pacific Human Placental Protein Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Human Placental Protein Sales Value, 2019-2030
5.5.2 South America Human Placental Protein Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Human Placental Protein Sales Value, 2019-2030
5.6.2 Middle East & Africa Human Placental Protein Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Placental Protein Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Placental Protein Sales Value
6.3 United States
6.3.1 United States Human Placental Protein Sales Value, 2019-2030
6.3.2 United States Human Placental Protein Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Placental Protein Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Placental Protein Sales Value, 2019-2030
6.4.2 Europe Human Placental Protein Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Placental Protein Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Placental Protein Sales Value, 2019-2030
6.5.2 China Human Placental Protein Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Placental Protein Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Placental Protein Sales Value, 2019-2030
6.6.2 Japan Human Placental Protein Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Placental Protein Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Placental Protein Sales Value, 2019-2030
6.7.2 South Korea Human Placental Protein Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Placental Protein Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Placental Protein Sales Value, 2019-2030
6.8.2 Southeast Asia Human Placental Protein Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Placental Protein Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Placental Protein Sales Value, 2019-2030
6.9.2 India Human Placental Protein Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Placental Protein Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Japan Bio Products GmbH
7.1.1 Japan Bio Products GmbH Profile
7.1.2 Japan Bio Products GmbH Main Business
7.1.3 Japan Bio Products GmbH Human Placental Protein Products, Services and Solutions
7.1.4 Japan Bio Products GmbH Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.1.5 Japan Bio Products GmbH Recent Developments
7.2 R&D Systems, Inc
7.2.1 R&D Systems, Inc Profile
7.2.2 R&D Systems, Inc Main Business
7.2.3 R&D Systems, Inc Human Placental Protein Products, Services and Solutions
7.2.4 R&D Systems, Inc Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.2.5 R&D Systems, Inc Recent Developments
7.3 Abcam Plc
7.3.1 Abcam Plc Profile
7.3.2 Abcam Plc Main Business
7.3.3 Abcam Plc Human Placental Protein Products, Services and Solutions
7.3.4 Abcam Plc Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.3.5 Clontech Laboratories, Inc Recent Developments
7.4 Clontech Laboratories, Inc
7.4.1 Clontech Laboratories, Inc Profile
7.4.2 Clontech Laboratories, Inc Main Business
7.4.3 Clontech Laboratories, Inc Human Placental Protein Products, Services and Solutions
7.4.4 Clontech Laboratories, Inc Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.4.5 Clontech Laboratories, Inc Recent Developments
7.5 Lee Biosolutions, Inc
7.5.1 Lee Biosolutions, Inc Profile
7.5.2 Lee Biosolutions, Inc Main Business
7.5.3 Lee Biosolutions, Inc Human Placental Protein Products, Services and Solutions
7.5.4 Lee Biosolutions, Inc Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.5.5 Lee Biosolutions, Inc Recent Developments
7.6 Kamiya Biomedical Company
7.6.1 Kamiya Biomedical Company Profile
7.6.2 Kamiya Biomedical Company Main Business
7.6.3 Kamiya Biomedical Company Human Placental Protein Products, Services and Solutions
7.6.4 Kamiya Biomedical Company Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.6.5 Kamiya Biomedical Company Recent Developments
7.7 Scripps Laboratories
7.7.1 Scripps Laboratories Profile
7.7.2 Scripps Laboratories Main Business
7.7.3 Scripps Laboratories Human Placental Protein Products, Services and Solutions
7.7.4 Scripps Laboratories Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.7.5 Scripps Laboratories Recent Developments
7.8 VWR International
7.8.1 VWR International Profile
7.8.2 VWR International Main Business
7.8.3 VWR International Human Placental Protein Products, Services and Solutions
7.8.4 VWR International Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.8.5 VWR International Recent Developments
7.9 Elabscience Biotechnology Co.,Ltd
7.9.1 Elabscience Biotechnology Co.,Ltd Profile
7.9.2 Elabscience Biotechnology Co.,Ltd Main Business
7.9.3 Elabscience Biotechnology Co.,Ltd Human Placental Protein Products, Services and Solutions
7.9.4 Elabscience Biotechnology Co.,Ltd Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.9.5 Elabscience Biotechnology Co.,Ltd Recent Developments
7.10 Hunan World Well-Being Bio-Tech Co., Ltd
7.10.1 Hunan World Well-Being Bio-Tech Co., Ltd Profile
7.10.2 Hunan World Well-Being Bio-Tech Co., Ltd Main Business
7.10.3 Hunan World Well-Being Bio-Tech Co., Ltd Human Placental Protein Products, Services and Solutions
7.10.4 Hunan World Well-Being Bio-Tech Co., Ltd Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.10.5 Hunan World Well-Being Bio-Tech Co., Ltd Recent Developments
7.11 Takara Bio Inc
7.11.1 Takara Bio Inc Profile
7.11.2 Takara Bio Inc Main Business
7.11.3 Takara Bio Inc Human Placental Protein Products, Services and Solutions
7.11.4 Takara Bio Inc Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.11.5 Takara Bio Inc Recent Developments
7.12 MED Skincare
7.12.1 MED Skincare Profile
7.12.2 MED Skincare Main Business
7.12.3 MED Skincare Human Placental Protein Products, Services and Solutions
7.12.4 MED Skincare Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.12.5 MED Skincare Recent Developments
7.13 CJT
7.13.1 CJT Profile
7.13.2 CJT Main Business
7.13.3 CJT Human Placental Protein Products, Services and Solutions
7.13.4 CJT Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.13.5 CJT Recent Developments
7.14 Charites Japan
7.14.1 Charites Japan Profile
7.14.2 Charites Japan Main Business
7.14.3 Charites Japan Human Placental Protein Products, Services and Solutions
7.14.4 Charites Japan Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.14.5 Charites Japan Recent Developments
7.15 Bioon
7.15.1 Bioon Profile
7.15.2 Bioon Main Business
7.15.3 Bioon Human Placental Protein Products, Services and Solutions
7.15.4 Bioon Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.15.5 Bioon Recent Developments
7.16 Japan Natural Laboratories
7.16.1 Japan Natural Laboratories Profile
7.16.2 Japan Natural Laboratories Main Business
7.16.3 Japan Natural Laboratories Human Placental Protein Products, Services and Solutions
7.16.4 Japan Natural Laboratories Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.16.5 Japan Natural Laboratories Recent Developments
7.17 Height Long Jiang Yinhe
7.17.1 Height Long Jiang Yinhe Profile
7.17.2 Height Long Jiang Yinhe Main Business
7.17.3 Height Long Jiang Yinhe Human Placental Protein Products, Services and Solutions
7.17.4 Height Long Jiang Yinhe Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.17.5 Height Long Jiang Yinhe Recent Developments
7.18 Albert David Ltd.
7.18.1 Albert David Ltd. Profile
7.18.2 Albert David Ltd. Main Business
7.18.3 Albert David Ltd. Human Placental Protein Products, Services and Solutions
7.18.4 Albert David Ltd. Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.18.5 Albert David Ltd. Recent Developments
7.19 MF3 LTD
7.19.1 MF3 LTD Profile
7.19.2 MF3 LTD Main Business
7.19.3 MF3 LTD Human Placental Protein Products, Services and Solutions
7.19.4 MF3 LTD Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.19.5 MF3 LTD Recent Developments
7.20 SR GROUP
7.20.1 SR GROUP Profile
7.20.2 SR GROUP Main Business
7.20.3 SR GROUP Human Placental Protein Products, Services and Solutions
7.20.4 SR GROUP Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.20.5 SR GROUP Recent Developments
7.21 SGSTEMCELL
7.21.1 SGSTEMCELL Profile
7.21.2 SGSTEMCELL Main Business
7.21.3 SGSTEMCELL Human Placental Protein Products, Services and Solutions
7.21.4 SGSTEMCELL Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.21.5 SGSTEMCELL Recent Developments
7.22 NOVA Biologics, Inc
7.22.1 NOVA Biologics, Inc Profile
7.22.2 NOVA Biologics, Inc Main Business
7.22.3 NOVA Biologics, Inc Human Placental Protein Products, Services and Solutions
7.22.4 NOVA Biologics, Inc Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.22.5 NOVA Biologics, Inc Recent Developments
7.23 Creative Enzymes
7.23.1 Creative Enzymes Profile
7.23.2 Creative Enzymes Main Business
7.23.3 Creative Enzymes Human Placental Protein Products, Services and Solutions
7.23.4 Creative Enzymes Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.23.5 Creative Enzymes Recent Developments
7.24 Melsmon Pharmaceutical Co., Ltd
7.24.1 Melsmon Pharmaceutical Co., Ltd Profile
7.24.2 Melsmon Pharmaceutical Co., Ltd Main Business
7.24.3 Melsmon Pharmaceutical Co., Ltd Human Placental Protein Products, Services and Solutions
7.24.4 Melsmon Pharmaceutical Co., Ltd Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.24.5 Melsmon Pharmaceutical Co., Ltd Recent Developments
7.25 Bovogen Biologicals Pty Ltd
7.25.1 Bovogen Biologicals Pty Ltd Profile
7.25.2 Bovogen Biologicals Pty Ltd Main Business
7.25.3 Bovogen Biologicals Pty Ltd Human Placental Protein Products, Services and Solutions
7.25.4 Bovogen Biologicals Pty Ltd Human Placental Protein Revenue (US$ Million) & (2019-2024)
7.25.5 Bovogen Biologicals Pty Ltd Recent Developments
8 Industry Chain Analysis
8.1 Human Placental Protein Industrial Chain
8.2 Human Placental Protein Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Placental Protein Sales Model
8.5.2 Sales Channel
8.5.3 Human Placental Protein Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Human Placental Protein Market Trends
    Table 2. Human Placental Protein Market Drivers & Opportunity
    Table 3. Human Placental Protein Market Challenges
    Table 4. Human Placental Protein Market Restraints
    Table 5. Global Human Placental Protein Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Human Placental Protein Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Human Placental Protein Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Human Placental Protein Product Type
    Table 9. Key Companies Time to Begin Mass Production of Human Placental Protein
    Table 10. Global Human Placental Protein Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Placental Protein as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Human Placental Protein Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Human Placental Protein Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Human Placental Protein Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Human Placental Protein Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Human Placental Protein Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Human Placental Protein Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Human Placental Protein Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Human Placental Protein Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Human Placental Protein Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Human Placental Protein Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Human Placental Protein Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Human Placental Protein Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Human Placental Protein Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Human Placental Protein Sales Value by Region (2019-2024) & (%)
    Table 27. Global Human Placental Protein Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Human Placental Protein Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Human Placental Protein Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Human Placental Protein Sales Value, (2025-2030) & (US$ Million)
    Table 31. Japan Bio Products GmbH Basic Information List
    Table 32. Japan Bio Products GmbH Description and Business Overview
    Table 33. Japan Bio Products GmbH Human Placental Protein Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Human Placental Protein Business of Japan Bio Products GmbH (2019-2024)
    Table 35. Japan Bio Products GmbH Recent Developments
    Table 36. R&D Systems, Inc Basic Information List
    Table 37. R&D Systems, Inc Description and Business Overview
    Table 38. R&D Systems, Inc Human Placental Protein Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Human Placental Protein Business of R&D Systems, Inc (2019-2024)
    Table 40. R&D Systems, Inc Recent Developments
    Table 41. Abcam Plc Basic Information List
    Table 42. Abcam Plc Description and Business Overview
    Table 43. Abcam Plc Human Placental Protein Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Human Placental Protein Business of Abcam Plc (2019-2024)
    Table 45. Abcam Plc Recent Developments
    Table 46. Clontech Laboratories, Inc Basic Information List
    Table 47. Clontech Laboratories, Inc Description and Business Overview
    Table 48. Clontech Laboratories, Inc Human Placental Protein Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Human Placental Protein Business of Clontech Laboratories, Inc (2019-2024)
    Table 50. Clontech Laboratories, Inc Recent Developments
    Table 51. Lee Biosolutions, Inc Basic Information List
    Table 52. Lee Biosolutions, Inc Description and Business Overview
    Table 53. Lee Biosolutions, Inc Human Placental Protein Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Human Placental Protein Business of Lee Biosolutions, Inc (2019-2024)
    Table 55. Lee Biosolutions, Inc Recent Developments
    Table 56. Kamiya Biomedical Company Basic Information List
    Table 57. Kamiya Biomedical Company Description and Business Overview
    Table 58. Kamiya Biomedical Company Human Placental Protein Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Human Placental Protein Business of Kamiya Biomedical Company (2019-2024)
    Table 60. Kamiya Biomedical Company Recent Developments
    Table 61. Scripps Laboratories Basic Information List
    Table 62. Scripps Laboratories Description and Business Overview
    Table 63. Scripps Laboratories Human Placental Protein Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Human Placental Protein Business of Scripps Laboratories (2019-2024)
    Table 65. Scripps Laboratories Recent Developments
    Table 66. VWR International Basic Information List
    Table 67. VWR International Description and Business Overview
    Table 68. VWR International Human Placental Protein Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Human Placental Protein Business of VWR International (2019-2024)
    Table 70. VWR International Recent Developments
    Table 71. Elabscience Biotechnology Co.,Ltd Basic Information List
    Table 72. Elabscience Biotechnology Co.,Ltd Description and Business Overview
    Table 73. Elabscience Biotechnology Co.,Ltd Human Placental Protein Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Human Placental Protein Business of Elabscience Biotechnology Co.,Ltd (2019-2024)
    Table 75. Elabscience Biotechnology Co.,Ltd Recent Developments
    Table 76. Hunan World Well-Being Bio-Tech Co., Ltd Basic Information List
    Table 77. Hunan World Well-Being Bio-Tech Co., Ltd Description and Business Overview
    Table 78. Hunan World Well-Being Bio-Tech Co., Ltd Human Placental Protein Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Human Placental Protein Business of Hunan World Well-Being Bio-Tech Co., Ltd (2019-2024)
    Table 80. Hunan World Well-Being Bio-Tech Co., Ltd Recent Developments
    Table 81. Takara Bio Inc Basic Information List
    Table 82. Takara Bio Inc Description and Business Overview
    Table 83. Takara Bio Inc Human Placental Protein Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Human Placental Protein Business of Takara Bio Inc (2019-2024)
    Table 85. Takara Bio Inc Recent Developments
    Table 86. MED Skincare Basic Information List
    Table 87. MED Skincare Description and Business Overview
    Table 88. MED Skincare Human Placental Protein Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Human Placental Protein Business of MED Skincare (2019-2024)
    Table 90. MED Skincare Recent Developments
    Table 91. CJT Basic Information List
    Table 92. CJT Description and Business Overview
    Table 93. CJT Human Placental Protein Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Human Placental Protein Business of CJT (2019-2024)
    Table 95. CJT Recent Developments
    Table 96. Charites Japan Basic Information List
    Table 97. Charites Japan Description and Business Overview
    Table 98. Charites Japan Human Placental Protein Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Human Placental Protein Business of Charites Japan (2019-2024)
    Table 100. Charites Japan Recent Developments
    Table 101. Bioon Basic Information List
    Table 102. Bioon Description and Business Overview
    Table 103. Bioon Human Placental Protein Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Human Placental Protein Business of Bioon (2019-2024)
    Table 105. Bioon Recent Developments
    Table 106. Japan Natural Laboratories Basic Information List
    Table 107. Japan Natural Laboratories Description and Business Overview
    Table 108. Japan Natural Laboratories Human Placental Protein Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Human Placental Protein Business of Japan Natural Laboratories (2019-2024)
    Table 110. Japan Natural Laboratories Recent Developments
    Table 111. Height Long Jiang Yinhe Basic Information List
    Table 112. Height Long Jiang Yinhe Description and Business Overview
    Table 113. Height Long Jiang Yinhe Human Placental Protein Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Human Placental Protein Business of Height Long Jiang Yinhe (2019-2024)
    Table 115. Height Long Jiang Yinhe Recent Developments
    Table 116. Albert David Ltd. Basic Information List
    Table 117. Albert David Ltd. Description and Business Overview
    Table 118. Albert David Ltd. Human Placental Protein Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Human Placental Protein Business of Albert David Ltd. (2019-2024)
    Table 120. Albert David Ltd. Recent Developments
    Table 121. MF3 LTD Basic Information List
    Table 122. MF3 LTD Description and Business Overview
    Table 123. MF3 LTD Human Placental Protein Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Human Placental Protein Business of MF3 LTD (2019-2024)
    Table 125. MF3 LTD Recent Developments
    Table 126. SR GROUP Basic Information List
    Table 127. SR GROUP Description and Business Overview
    Table 128. SR GROUP Human Placental Protein Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Human Placental Protein Business of SR GROUP (2019-2024)
    Table 130. SR GROUP Recent Developments
    Table 131. SGSTEMCELL Basic Information List
    Table 132. SGSTEMCELL Description and Business Overview
    Table 133. SGSTEMCELL Human Placental Protein Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Human Placental Protein Business of SGSTEMCELL (2019-2024)
    Table 135. SGSTEMCELL Recent Developments
    Table 136. NOVA Biologics, Inc Basic Information List
    Table 137. NOVA Biologics, Inc Description and Business Overview
    Table 138. NOVA Biologics, Inc Human Placental Protein Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Human Placental Protein Business of NOVA Biologics, Inc (2019-2024)
    Table 140. NOVA Biologics, Inc Recent Developments
    Table 141. Creative Enzymes Basic Information List
    Table 142. Creative Enzymes Description and Business Overview
    Table 143. Creative Enzymes Human Placental Protein Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Human Placental Protein Business of Creative Enzymes (2019-2024)
    Table 145. Creative Enzymes Recent Developments
    Table 146. Melsmon Pharmaceutical Co., Ltd Basic Information List
    Table 147. Melsmon Pharmaceutical Co., Ltd Description and Business Overview
    Table 148. Melsmon Pharmaceutical Co., Ltd Human Placental Protein Products, Services and Solutions
    Table 149. Revenue (US$ Million) in Human Placental Protein Business of Melsmon Pharmaceutical Co., Ltd (2019-2024)
    Table 150. Melsmon Pharmaceutical Co., Ltd Recent Developments
    Table 151. Bovogen Biologicals Pty Ltd Basic Information List
    Table 152. Bovogen Biologicals Pty Ltd Description and Business Overview
    Table 153. Bovogen Biologicals Pty Ltd Human Placental Protein Products, Services and Solutions
    Table 154. Revenue (US$ Million) in Human Placental Protein Business of Bovogen Biologicals Pty Ltd (2019-2024)
    Table 155. Bovogen Biologicals Pty Ltd Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Human Placental Protein Downstream Customers
    Table 159. Human Placental Protein Distributors List
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
    Table 163. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Human Placental Protein Product Picture
    Figure 2. Global Human Placental Protein Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Human Placental Protein Sales Value (2019-2030) & (US$ Million)
    Figure 4. Human Placental Protein Report Years Considered
    Figure 5. Global Human Placental Protein Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Placental Protein Revenue in 2023
    Figure 7. Human Placental Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Hydrolyzed Human Placental Protein Picture
    Figure 9. Human Placental Enzymes Picture
    Figure 10. Others Picture
    Figure 11. Global Human Placental Protein Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Human Placental Protein Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Life Science
    Figure 14. Product Picture of Tumor Markers
    Figure 15. Product Picture of Testing/Assay Validation
    Figure 16. Product Picture of Others
    Figure 17. Global Human Placental Protein Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Human Placental Protein Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Human Placental Protein Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Human Placental Protein Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Human Placental Protein Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Human Placental Protein Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Human Placental Protein Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Human Placental Protein Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Human Placental Protein Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Human Placental Protein Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Human Placental Protein Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Human Placental Protein Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Human Placental Protein Sales Value (%), (2019-2030)
    Figure 30. United States Human Placental Protein Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Human Placental Protein Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Human Placental Protein Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Human Placental Protein Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Human Placental Protein Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Human Placental Protein Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Human Placental Protein Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Human Placental Protein Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Human Placental Protein Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Human Placental Protein Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Human Placental Protein Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Human Placental Protein Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Human Placental Protein Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Human Placental Protein Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Human Placental Protein Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Human Placental Protein Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Human Placental Protein Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Human Placental Protein Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Human Placental Protein Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Human Placental Protein Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Human Placental Protein Sales Value by Application (%), 2023 VS 2030
    Figure 51. Human Placental Protein Industrial Chain
    Figure 52. Human Placental Protein Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona